盘龙药业：酮洛芬凝胶贴膏获国家药品监督管理局临床试验批准

Core Viewpoint - The company has received approval from the National Medical Products Administration for clinical trials of Ketoprofen Gel Patch, indicating progress in its product development pipeline [1] Group 1: Product Details - The Ketoprofen Gel Patch is specified to be 14cm x 10cm in size, containing 10g of gel and 30mg of Ketoprofen [1] - The indications for the product include pain relief and anti-inflammatory treatment for conditions such as osteoarthritis, periarthritis of the shoulder, tendinitis, de Quervain's tenosynovitis, lateral epicondylitis (tennis elbow), muscle pain, and swelling and pain due to trauma [1] - The administration method is local application, with one patch applied twice daily [1] Group 2: Regulatory Classification - The product is classified as a Class 3 chemical drug according to registration standards [1]